H5

Aaron L Graber1,2,3, Holly C Simmons1, Kevin R McCarthy1,3

  • 1Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

PLoS pathogens
|March 4, 2026
PubMed
概括

针对流感血质素 (HA) 蛋白的广泛保护性抗体对于对抗新型病毒至关重要. 然而,一种特定的病毒突变 (P221S) 允许一些流感菌株逃避这些基本的人类免疫反应.